CLEARBRIDGE ENERGY MIDSTREAM (EMO)

US18469P2092

45.21  +0.21 (+0.47%)

Fundamental Rating

2

Taking everything into account, EMO scores 2 out of 10 in our fundamental rating. EMO was compared to 0 industry peers in the Unkown industry. EMO has a bad profitability rating. Also its financial health evaluation is rather negative. EMO does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year EMO was profitable.
EMO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EMO reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: EMO reported negative operating cash flow in multiple years.

1.2 Ratios

Industry RankSector Rank
ROA -5.8%
ROE -8.73%
ROIC N/A
ROA(3y)19.54%
ROA(5y)-10.22%
ROE(3y)28.55%
ROE(5y)-14.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EMO has less shares outstanding
EMO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for EMO has remained at the same level compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that EMO is in the distress zone and has some risk of bankruptcy.
EMO has a debt to FCF ratio of 6.57. This is a slightly negative value and a sign of low solvency as EMO would need 6.57 years to pay back of all of its debts.
EMO has a Debt/Equity ratio of 0.50. This is a neutral value indicating EMO is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.57
Altman-Z 0.98
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 4.60 indicates that EMO has no problem at all paying its short term obligations.
A Quick Ratio of 4.60 indicates that EMO has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 4.6

3

3. Growth

3.1 Past

The earnings per share for EMO have decreased strongly by -55.15% in the last year.
Looking at the last year, EMO shows a very strong growth in Revenue. The Revenue has grown by 51.01%.
Measured over the past years, EMO shows a very strong growth in Revenue. The Revenue has been growing by 25.08% on average per year.
EPS 1Y (TTM)-55.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2714.33%
Revenue 1Y (TTM)51.01%
Revenue growth 3Y29.33%
Revenue growth 5Y25.08%
Sales Q2Q%55.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.90, which indicates a very decent valuation of EMO.
EMO is valuated cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.9
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 18.59
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.38%, EMO is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.36, EMO pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.38%

5.2 History

The dividend of EMO decreases each year by -14.49%.
EMO has paid a dividend for at least 10 years, which is a reliable track record.
EMO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.49%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

The earnings of EMO are negative and hence is the payout ratio. EMO will probably not be able to sustain this dividend level.
DP-75.8%
EPS Next 2YN/A
EPS Next 3YN/A

CLEARBRIDGE ENERGY MIDSTREAM

NYSE:EMO (12/23/2024, 8:04:00 PM)

45.21

+0.21 (+0.47%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.38%
Inst Owner Change159.57%
Ins OwnersN/A
Ins Owner Change-90.16%
Market Cap578.24M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 7.38%
Dividend Growth(5Y)-14.49%
DP-75.8%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-21 2025-02-21 (0.33)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.9
Fwd PE N/A
P/S 61.25
P/FCF 18.59
P/OCF 18.59
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)5.08
EY11.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.43
FCFY5.38%
OCF(TTM)2.43
OCFY5.38%
SpS0.74
BVpS31.88
TBVpS31.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.8%
ROE -8.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 329.45%
ROA(3y)19.54%
ROA(5y)-10.22%
ROE(3y)28.55%
ROE(5y)-14.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.57
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.6
Quick Ratio 4.6
Altman-Z 0.98
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2714.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.01%
Revenue growth 3Y29.33%
Revenue growth 5Y25.08%
Sales Q2Q%55.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y210.28%
FCF growth 3Y-56.95%
FCF growth 5Y-19.69%
OCF growth 1Y210.28%
OCF growth 3Y-56.95%
OCF growth 5Y-19.69%